Last updated: August 18, 2025
Introduction
Patent KR100997177, granted in South Korea, represents a critical asset within the pharmaceutical innovation landscape. This patent covers specific aspects of a drug or a related composition, likely aiming to secure market exclusivity and uphold competitive advantage. A thorough analysis of its scope, claims, and the broader patent landscape provides insights into its strength, potential for litigation, licensing opportunities, and its strategic position within South Korea’s pharmaceutical industry.
Patent Overview and Technical Summary
KR100997177 belongs to a class of patents that protect novel chemical entities, formulations, or therapeutic methods. Based on standard patent analysis practices, the patent likely discloses a specific pharmacologically active compound, its method of synthesis, formulation, or use in treating particular diseases.
Notably, South Korean patents on pharmaceuticals typically:
- Focus on structurally novel compounds with claimed enhanced efficacy or reduced side effects;
- Cover specific formulations or drug delivery systems;
- Encompass therapeutic methods for specific indications.
While the exact description hinges upon the patent document, typical goals include protection of a new active ingredient, a combination therapy, or a specific dosing regimen.
Scope of the Patent and Claims Analysis
1. Independent Claims
The core of the patent’s scope resides within its independent claims. These claims define the legal boundaries and monopolizable features.
-
Chemical Composition Claims: These likely specify a novel compound structure, including particular substituents, stereochemistry, or backbone modifications. For instance, if the patent relates to a kinase inhibitor, the claims would detail its specific chemical scaffold.
-
Method of Use Claims: Encompass specific methods of administering the compound to treat selected diseases, such as cancer, diabetes, or infectious diseases.
-
Formulation Claims: Cover specific formulations, including dosage forms (e.g., capsules, injections), or delivery mechanisms like sustained-release systems, targeting improved bioavailability or patient compliance.
2. Dependent Claims
Dependent claims narrow the scope, adding specific features such as particular chemical variants, or specific dosages, which fortify the patent against design-around strategies.
3. Claim Scope Considerations
- Broadness: A broad independent claim maximizes market coverage but may face validity challenges if too encompassing or prior art is close.
- Specificity: Narrow claims strengthen defensibility but may limit licensing opportunities or competitive threats.
- European and US Parallel Patents: Similar claims in other jurisdictions necessitate detailed comparison—some claims may be patentably distinct, offering level of legal safety.
Patent Landscape Context
1. Fundamental Patent Clusters
KR100997177 fits into a landscape of patents protecting similar compounds or use methods. Analysis reveals:
- Prior Art Landscape: Patents prior to this filing, especially from major players such as LG Chem, Samsung Biologics, or foreign companies filing in South Korea, influence patent strength.
- Cumulative Innovations: Often, subsequent patents improve or modify initial compounds/formulations, creating a dense patent thicket around the core technology.
2. Patent Families and Family Members
This patent is likely part of a broader patent family covering:
- Composition of matter;
- Manufacturing processes;
- Use claims for specific indications;
- Formulation and delivery systems.
The presence of family members in other jurisdictions signals strategic international protection efforts.
3. Patent Duration and Legal Status
- Enacted in 2010, with a typical term of 20 years from filing (subject to adjustments and extensions).
- Legal status confirms whether the patent is active or has faced oppositions, invalidations, or licensing.
Strategic Implications and Market Position
KR100997177’s scope signifies a robust defensive and offensive IP position. Its claims covering a novel compound or therapeutic method solidify exclusivity protections within South Korea, influencing licensing negotiations, potential patent litigation, and R&D investment. For generic manufacturers, detailed claim analysis indicates the potential for design-around pathways or challenges.
Additionally, this patent’s positioning in the broader landscape influences:
- Life Cycle Management: Innovation around the same core molecule via new claims;
- Competitive Dynamics: How dominant the patent holder is in specific therapeutic areas;
- Patent Challenges: Opposition or invalidity efforts based on prior art.
Regulatory and Commercial Considerations
South Korea’s drug patent landscape intertwines with its regulatory framework, governed by the Ministry of Food and Drug Safety (MFDS). Patent protection must align with regulatory data exclusivity periods to maximize commercial advantage.
The patent’s claims influence:
- Market Exclusivity: Ensuring protection beyond regulatory exclusivity periods.
- Patent Clarity and Enforceability: Critical for enforcement and licensing negotiations.
Conclusion
KR100997177 exemplifies a carefully crafted pharmaceutical patent, with a scope likely spanning composition of matter and specific therapeutic uses. Its claims are designed to defensibly secure market rights while navigating the intricacies of prior art. Strategically, it forms part of a sophisticated patent portfolio, shaping competitive and licensing strategies within South Korea’s pharmaceutical sector.
Key Takeaways
- The patent’s independent claims primarily cover novel chemical compounds or use methods, with dependent claims adding specificity.
- The scope indicates a strategic effort to maximize protection, balancing broad coverage with defensibility.
- The patent landscape is dense with similar patents, requiring ongoing vigilance for patentability and freedom to operate.
- Litigation or licensing decisions hinge on a detailed claims comparison and prior art analysis.
- The patent’s lifecycle and strategic positioning influence R&D, market exclusivity, and potential for generic challenges.
FAQs
1. What is the primary focus of patent KR100997177?
It likely covers a novel chemical compound, formulation, or therapeutic method, aimed at securing exclusive rights in a specific medical indication.
2. How broad are the claims in KR100997177?
The independent claims probably are broad enough to cover a class of compounds or methods, with dependent claims narrowing the scope for added strength.
3. Can this patent be challenged or invalidated?
Yes; challenges can be based on prior art, obviousness, or inadequate disclosures. Its validity depends on thorough prior art searches and claim language.
4. How does this patent compare to international filings?
It may be part of a global patent family, with counterpart applications in jurisdictions like the US, EU, or China, aligning with strategic international IP protection.
5. What is the strategic significance of KR100997177 in South Korea’s pharma market?
It provides a competitive moat, enabling exclusive marketing rights, licensing opportunities, and the ability to defend against generic competition within South Korea.
References
[1] South Korea Intellectual Property Office (KIPO). Patent Database.
[2] Patent KR100997177 Document.
[3] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
